期刊文献+

卵巢浆液性腺癌组织中MMP-2、MT1-MMP的表达变化及意义 被引量:2

Expression and mechanism of MMP-2 and MT1-MMP in ovarian serous adenocarcinoma tissue
下载PDF
导出
摘要 目的观察卵巢浆液性腺癌中的基质金属蛋白酶-2(MMP-2)、膜型基质金属蛋白酶-1(MT1-MMP)的表达变化。方法采用免疫组化PV6000法检测50例卵巢浆液性腺癌、30例卵巢交界性浆液性腺瘤和30例卵巢良性浆液性腺瘤组织中的MMP-2、MT1-MMP。结果MMP-2和MT1-MMP在卵巢浆液性腺癌和交界性浆液性腺瘤中的表达阳性率高于良性浆液性腺瘤(P<0.05)。卵巢良性浆液性腺瘤组织中的MMP-2、MT1-MMP与病理分级、淋巴结转移、临床分期和预后有关(P均<0.05)。卵巢浆液性腺癌中MMP-2、MT1-MMP的表达呈正相关(rs=0.61,P<0.01)。结论卵巢浆液性腺癌中MMP-2、MT1-MMP表达上调。二者在卵巢浆液性腺癌的发生、浸润和转移中过程中协同发挥重要作用,可作为判断肿瘤恶性程度和预后的重要指标。 Objective To observe the the expression of MMP-2 and MT1-MMP in ovarian serous adenocarcinoma tissue, and explore its mechanism. Method Immunohistachemical PV6000 method was used to detect the expression of MMP- 2 and MT1-MMP in 30 benign serous adenomas,30 borderline serous adenomas and 50 serous adeneeareinomas of ovary. Results The positive expression rates of MMP-2 and MT1-MMP in human ovarian serous adenocarcinomas and borderline serous adenomas were higher than that in human benign serous adenomas (P 〈 0.05 ). The positive expression rates of MMP-2 and MT1-MMP were significantly related to the metastasis ,clinical stage and histological grade of human ovarian serous adeneoarcinomas( P 〈 0.05 ). The positive expression rates of MMP-2 and MT1-MMP in patients who dead in 2 years were grcady higher than that beyard 2 years ( P 〈 0.05). There was a positive correlationship between the expression of MT1-MMP and MMP-2 in serous adenocarcinomas of ovary ( r, = 0.61, P 〈 0.01 ). Conclusion MMP-2 and MT1-MMP may play grate role in the origin, invasion and metastasis of ovarian serous adenacarcinomas, and be act as an important index to predict the biological behavior in carcinoma.
出处 《山东医药》 CAS 北大核心 2010年第6期4-6,共3页 Shandong Medical Journal
关键词 卵巢肿瘤 卵巢浆液性腺癌 基质金属蛋白酶 转移 ovarian neoplasm ovarian carcinoma matrix metalloproteinase metastasis
  • 相关文献

参考文献10

  • 1Sato H, Takino T, Okada M, et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells[ J ]. Nature, 1994,370 (6484) :61-65.
  • 2Yang X, Staten ED, Howard JM, et al. Invassiveness and MMP expression in pancreatic carcinoma[ J]. J Surg Res,2001,98 ( 1 ) : 33 -39.
  • 3Sakata K, Shigemasa K, Nagai N, et al. Expression of matri metalloproteinases (MMP-2, MMP-9, MTI-MMP ) and their inhibitors (TIMP-1 ,TIMP-2) in common epithelial tumors of the ovary [J].Int J Oncol,2000,17(4) : 673-681.
  • 4Murthi P, Barker G, Nowell C J, et al. Plasminogen fragmention and increased production of extracenular matrix-degrading proteinase are associated with serous epithelial ovarian progression[ J]. Gynecol Oncol,2004,92( 1 ) : 80-88.
  • 5Seiki M . Membrane-type 1 matrix metalloproteinase:a key enzyme for tumor invasion[J]. Cancer Lea ,2003,194 ( 1 ) : 1 - 11.
  • 6顾学文,陈月香,肖芹,崔飞.MMP-2和TIMP-2在胃癌组织中的表达及其意义[J].实用癌症杂志,2003,18(1):50-51. 被引量:9
  • 7Bando E, Yonemura Y, Endou Y, et al. Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis[J].Oncol Res,1998,5(6) :1483-1488.
  • 8Sakakibara M, Koizumi S, Saikawa Y, et al. Membrane-type matrixmetalloproteinase-1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastoma[ J ]. Cancer, 1999,85( 1 ) :231-239.
  • 9Merati K, Said-Siadaty M, Andea A, et al. Expression of inflammatory modulator COX-2 in pancreatic ductal adenocaxcinoma and its relationship to pathologic and clinical parameters[ J]. Am J Clin Oncol,2001,24(5 ) :447-452.
  • 10Theret N, Musso O, L'Helgouale A, et al. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases ( MTMMPs) in association with MMP'2 activation in injured human livers[J].Am J Pathol,1998,153(3) :945-954.

二级参考文献1

共引文献8

同被引文献22

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部